CYT - Cyteir Therapeutics Inc. (CYT) CEO Dr. Markus Renschler on Q4 2021 Results - Earnings Call Transcript

Cyteir Therapeutics, Inc. (CYT) Q4 2021 Results Conference Call March 16, 2022 04:30 PM ET Company Participants Lisa Hayes - VP, IR and Corporate Communications Dr. Markus Renschler - President and CEO Dave Gaiero - VP, Finance Andrew Gengos - Chief Business Officer Paul Secrist - Chief Scientific Officer Conference Call Participants Anupam Rama - JP Morgan Jeff Hung - Morgan Stanley Tazeen Ahmad - Bank of America Robert Driscoll - Wedbush Securities Tim Chiang - Northland Securities Presentation Operator Good morning and welcome to Cyteir’s Fourth Quarter and Full Year 2021 Earnings Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Cyteir’s request. I would now like to turn the call over to Lisa Hayes, Vice President of Investor Relations and Corporate Communications. Lisa Hayes Good afternoon and

For further details see:

Cyteir Therapeutics, Inc. (CYT) CEO Dr. Markus Renschler on Q4 2021 Results - Earnings Call Transcript